Idiopathic Interstitial Pneumonia
📧 Sign up to get email alerts when something new happens for Idiopathic Interstitial Pneumonia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS other · 2026-04-16Clinical Trial Update: RaDiCo PID Cohort (RaDiCo-ILD Cohort in English)
RaDiCo PID Cohort (RaDiCo-ILD) trial in pediatric and adult patients with idiopathic interstitial pneumonia/ILD has been terminated.
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Japanese Idiopathic Interstitial Pneumonias Registry
Update on the Japanese Idiopathic Interstitial Pneonias Registry, a clinical trials registry sponsored by North East Japan Study Group, curr…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: FAPI PET for Lung Fibrosis [EARLY_Phase 1]
An early-phase Phase 1 trial evaluating FAPI PET imaging for interstitial lung disease and pulmonary fibrosis is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: P4O2 ILD Extension
A clinical trial update describes an extension of the P4O2 interstitial lung disease study led by Amsterdam UMC (VUmc) and currently recruit…
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: Molecular Diagnosis of Idiopathic Interstitial Pneumonias: a Prospective Study
A completed prospective study investigating molecular diagnosis for idiopathic interstitial pneumonias.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-01-09Clinical Trial Update: Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease [Phase 1, Phase 2]
Phase 1/2 trial evaluating safety and efficacy of allogeneic mesenchymal stem cells in rapidly progressive interstitial lung disease, comple…
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP) [Phase 2]
A Phase 2 trial evaluated riociguat for symptomatic pulmonary hypertension associated with idiopathic interstitial pneumonia, but the study …
-
EMA safety_alert · 2016-06-24Adempas not for use in patients with pulmonary hypertension caused by idiopathic interstitial pneumonia
The EMA guidance states that Adempas (riociguat) should not be used in patients with pulmonary hypertension due to idiopathic interstitial p…